Share-based Payment Arrangement, Expense in USD of PDS Biotechnology Corp from 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
PDS Biotechnology Corp quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2013 to Q3 2025.
  • PDS Biotechnology Corp Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $1.25M, a 29.9% decline year-over-year.
  • PDS Biotechnology Corp Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $4.59M.
  • PDS Biotechnology Corp annual Share-based Payment Arrangement, Expense for 2024 was $6.85M, a 10.1% decline from 2023.
  • PDS Biotechnology Corp annual Share-based Payment Arrangement, Expense for 2023 was $7.61M, a 46.5% increase from 2022.
  • PDS Biotechnology Corp annual Share-based Payment Arrangement, Expense for 2022 was $5.2M, a 27.5% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

PDS Biotechnology Corp Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $4.59M $1.25M -$532K -29.9% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $5.12M $448K -$1.35M -75.1% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 $6.47M $1.25M -$376K -23.1% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $6.85M $1.64M 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025
Q3 2024 $1.78M 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 $1.8M 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025
Q1 2024 $1.63M 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2022 $5.2M $1.37M -$299K -17.9% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 $5.5M $1.34M -$357K -21% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $5.85M $1.35M +$907K +205% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2022
Q1 2022 $4.95M $1.13M +$871K +338% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2022
Q4 2021 $4.07M $1.67M +$1.54M +1173% 01 Oct 2021 31 Dec 2021 10-K 28 Mar 2023
Q3 2021 $2.53M $1.7M +$1.57M +1211% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 $960K $442K +$395K +858% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022
Q1 2021 $565K $258K +$133K +106% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022
Q4 2020 $432K $131K -$114K -46.4% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 $546K $130K +$9.59K +7.98% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 $537K $46.1K +$27.5K +148% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 $509K $125K -$2.63M -95.5% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 $3.14M $245K +$86.8K +54.7% 01 Oct 2019 31 Dec 2019 10-K 18 Mar 2021
Q3 2019 $3.05M $120K +$78.5K +188% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020
Q2 2019 $2.97M $18.6K -$26K -58.4% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020
Q1 2019 $3M $2.75M +$2.75M +39171% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020
Q4 2018 $252K $159K -$1.39M -89.7% 01 Oct 2018 31 Dec 2018 10-K 27 Mar 2020
Q3 2018 $1.64M $41.7K -$1.53M -97.3% 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019
Q2 2018 $3.17M $44.6K -$1.54M -97.2% 01 Apr 2018 30 Jun 2018 10-Q 01 Aug 2019
Q1 2018 $4.7M $7.02K -$1.48M -99.5% 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019
Q4 2017 $6.18M $1.55M +$270K +21.2% 01 Oct 2017 31 Dec 2017 10-K 21 Feb 2019
Q3 2017 $5.91M $1.57M +$338K +27.4% 01 Jul 2017 30 Sep 2017 10-Q 01 Nov 2018
Q2 2017 $5.58M $1.58M +$200K +14.4% 01 Apr 2017 30 Jun 2017 10-Q 01 Aug 2018
Q1 2017 $5.38M $1.49M +$70.4K +4.97% 01 Jan 2017 31 Mar 2017 10-Q 01 May 2018
Q4 2016 $5.31M $1.28M -$57K -4.28% 01 Oct 2016 31 Dec 2016 10-K 01 Mar 2018
Q3 2016 $5.36M $1.23M +$621K +102% 01 Jul 2016 30 Sep 2016 10-Q 01 Nov 2017
Q2 2016 $4.74M $1.38M +$797K +137% 01 Apr 2016 30 Jun 2016 10-Q 01 Aug 2017
Q1 2016 $3.94M $1.42M +$1.04M +281% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017
Q4 2015 $2.9M $1.33M 01 Oct 2015 31 Dec 2015 10-K 01 Mar 2018
Q3 2015 $612K +$332K +119% 01 Jul 2015 30 Sep 2015 10-Q 01 Nov 2016
Q2 2015 $584K 01 Apr 2015 30 Jun 2015 10-Q 03 Aug 2016
Q1 2015 $371K 01 Jan 2015 31 Mar 2015 10-Q 03 May 2016
Q3 2014 $280K 01 Jul 2014 30 Sep 2014 10-Q 06 Nov 2015

PDS Biotechnology Corp Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $6.85M -$766K -10.1% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025
2023 $7.61M +$2.42M +46.5% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025
2022 $5.2M +$1.12M +27.5% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 $4.07M +$3.64M +842% 01 Jan 2021 31 Dec 2021 10-K 28 Mar 2023
2020 $432K -$2.71M -86.2% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 $3.14M +$2.89M +1146% 01 Jan 2019 31 Dec 2019 10-K 18 Mar 2021
2018 $252K -$5.93M -95.9% 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020
2017 $6.18M +$878K +16.5% 01 Jan 2017 31 Dec 2017 10-K 21 Feb 2019
2016 $5.31M +$2.41M +83% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2018
2015 $2.9M +$1.6M +123% 01 Jan 2015 31 Dec 2015 10-K 01 Mar 2018
2014 $1.3M +$1.04M +399% 01 Jan 2014 31 Dec 2014 10-K 02 Mar 2017
2013 $260K 01 Jan 2013 31 Dec 2013 10-K 08 Mar 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.